Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Women’s health

HRT not always linked with cognitive decline, study finds

Hormone replacement therapy (HRT) is not linked with cognitive harm in healthy women intiating treatment in their early 50s, a study has found.

Research, which was presented at the Alzheimer’s Association International Conference (AAIC) in Chicago, Illinois on 23 July 2018, investigated why results from two “influential” studies differed from previous findings linking HRT with cognitive decline.

Researchers looked at two more recent studies and found no negative effect on cognition in women who had initiated HRT between ages 50 and 54 years.

However, those who took HRT when aged between 65 and 79 years did have reductions in global cognition, working memory and executive functioning.

Women with type 2 diabetes on HRT also showed a higher risk of cognitive impairment compared with non-diabetic women on HRT and diabetic women given placebo.

“These findings add to our understanding of the complex effects of hormones on the brain,” said Carey Gleason, a researcher at the Wisconsin Alzheimer’s Disease Research Center in Madison, Wisconsin.

“These data are sorely needed to guide women’s healthcare during and after the menopausal transition and to help women make personalised and informed decisions regarding management of their menopausal symptoms and the prevention of future adverse health outcomes.”

Doug Brown, chief policy and research officer at Alzheimer’s Society, said: “Healthy women who started taking HRT in their early 50s, shortly after menopause, can feel reassured, as this research suggests there isn’t a link to brain decline with taking HRT from this time.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205246

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Lecture Notes in Pharmacy Practice

    Lecture Notes in Pharmacy Practice

    A comprehensive study guide which summarises the basic principles in pharmacy practice. Clear, bulleted information for quick reference.

    £43.00Buy now
  • MCQs in Pharmacy Practice

    MCQs in Pharmacy Practice

    A study aid with 800 MCQs. Assess your knowledge, analytical skills, and ability to apply this knowledge base in clinical practice.

    £25.00Buy now
  • Social and Cognitive Pharmacy

    Social and Cognitive Pharmacy

    Social and Cognitive Pharmacy is a practical handbook for learning and teaching sociology and psychology, and applying this to pharmacy practice.

    £33.00Buy now
  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £28.00Buy now
  • Introduction to Pharmaceutical Calculations

    Introduction to Pharmaceutical Calculations

    Introduction to Pharmaceutical Calculations is an essential study aid for pharmacy students. The book contains worked examples and sample questions and answers.

    £33.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.